| HOME >> MEDICINE >> TECHNOLOGY |
61,719,57560,634,84961,536,05060,269,804
Solta Medical, Inc.NON-GAAP RECONCILIATION OF GROSS MARGIN, OPERATING INCOME (LOSS), EBITDA, NET INCOME (LOSS) AND NET INCOME (LOSS) PER SHARE (in thousands, except share and per share data)(unaudited)Three Months EndedSix Months EndedJune 30,June 30,2012201120122011GAAP Gross margin
$23,548$18,563$43,791$36,624GAAP gross margin as % of sales
63%64%63%66%Non-GAAP adjustments to gross margin:GAAP Gross margin
$23,548$18,563$43,791$36,624Amortization and other non-cash acquisition related charges
1,3758443,0331,689Stock-based compensation
12795239164Non-GAAP gross margin
$25,050$19,502$47,063$38,477Non-GAAP gross margin as % of sales
67%67%68%69%GAAP loss from operations
($25,753)($124)($34,121)($1,172)Non-GAAP adjustments to net income (loss) from operations:Amortization and other non-cash acquisition related charges
1,7291,1283,7462,202Remeasurement of contingent consideration liability
26,000(484)30,700(484)Acquisition-related expenses
58120151120Severance expenses (credits)
(11)—19—Stock-based compensation
1,2098122,3491,481Non-GAAP income from operations
$3,232$1,452$2,844$2,147Depreciation expenses
9377631,8751,545Non-GAAP EBITDA
$4,169$2,215$4,719$3,692GAAP net loss($26,286)($206)($35,085)($1,231)Non-GAAP adjustments to net loss:Amortization and other non-cash acquisition related charges
1,7291,1283,7462,202Remeasurement of contingent consideration liability
26,000(484)30,700(484)Acquisition-related expenses
58120151120Severance expenses (credits)
(11)—19—Stock-based compensation
1,2098122,3491,481Non-GAAP net income
$2,699$1,370$1,880$2,088GAAP basic net loss per share
($0.43)($0.00)($0.57)($0.02)Non-GAAP a
'/>"/>
| SOURCE Solta Medical, Inc. Copyright©2012 PR Newswire. All rights reserved |